NRC Health

NRC ·Healthcare, Diagnostics & Research, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $22.9M $20.5M $17.6M $18.2M $15.5M $15.1M $11.6M $11.6M
Depreciation & Amortization $4.6M $4.2M $4.1M $3.8M $3.7M $4.7M $5.1M $4.7M
Depreciation
Amortization $610.0K $654.0K $995.0K $876.0K $954.0K $1.3M $1.6M $1.3M
Stock-Based Compensation $1.8M $1.9M $1.4M $742.0K $955.0K $388.0K $763.0K $779.0K
Net Cash from Operating Activities $28.1M $26.8M $21.9M $26.2M $19.3M $19.1M $18.5M $14.6M
Investing Activities
Capital Expenditures $4.6M $4.0M $2.9M $2.5M $2.2M $2.3M $2.8M $1.5M
Business Acquisitions $2.6M $4.1M $15.4M
Net Cash from Investing Activities $-6.1M $-3.8M $-1.3M $-5.7M $-2.2M $-2.3M $-6.9M $-17.0M
Financing Activities
Dividends Paid $16.9M $28.6M $10.1M $2.1M $17.4M $5.9M $5.1M
Stock Repurchases $1.7M $399.0K
Net Cash from Financing Activities $-21.1M $-32.5M $-16.9M $-1.7M $-2.8M $-16.7M $-6.9M $3.3M
Net Change in Cash $1.7M $-9.1M $2.1M $18.0M $13.8M $204.0K $4.6M $1.0M
Free Cash Flow $23.5M $22.9M $18.9M $23.7M $17.1M $16.8M $15.7M $13.1M
← Newer Page 2 of 3 Older →